ID

15117

Description

Effect of Liraglutide on Weight and Appetite in Obese Subjects With Type 2 Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT01508949

Lien

https://clinicaltrials.gov/show/NCT01508949

Mots-clés

Versions (1)
  1. 16/05/2016 16/05/2016 -
Téléchargé le

16 mai 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Diabetes NCT01508949

Anglais

Eligibility Diabetes NCT01508949

1 Formulaires  
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01508949
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
type 2 diabetes mellitus
Description

diabetes mellitus type 2

Type de données

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0441730
diet treated and/or subjects in monotherapy with sulphonylurea or repaglinide
Description

diet therapy; sulphonylurea or repaglinide

Type de données

boolean

Alias
UMLS CUI [1]
C0012159
UMLS CUI [2]
C0038766
UMLS CUI [3]
C0246689
hba1c for diet treated subjects 6.5-12%, both inclusive
Description

hba1c

Type de données

boolean

Alias
UMLS CUI [1]
C0019018
hba1c for sulphonylurea or repaglinide treated subjects maximum 10%
Description

hba1c for sulphonylurea or repaglinide treated subjects

Type de données

boolean

Alias
UMLS CUI [1,1]
C0038766
UMLS CUI [1,2]
C0019018
UMLS CUI [2,1]
C0246689
UMLS CUI [2,2]
C0019018
body mass index (bmi) at least 27 kg/m^2
Description

bmi

Type de données

boolean

Alias
UMLS CUI [1]
C1305855
euthyroid subjects
Description

euthyroid

Type de données

boolean

Alias
UMLS CUI [1]
C0117002
fasting blood glucose 7-14 mmol/l
Description

fasting blood glucose

Type de données

boolean

Alias
UMLS CUI [1]
C0428568
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
impaired liver function
Description

impaired liver function

Type de données

boolean

Alias
UMLS CUI [1]
C0086565
impaired renal function
Description

impaired renal function

Type de données

boolean

Alias
UMLS CUI [1]
C0151746
cardiac problems
Description

cardiac problems

Type de données

boolean

Alias
UMLS CUI [1]
C0262402
uncontrolled treated/untreated hypertension
Description

hypertension

Type de données

boolean

Alias
UMLS CUI [1]
C0020538
recurrent severe hypoglycaemia as judged by the investigator
Description

hypoglycaemia

Type de données

boolean

Alias
UMLS CUI [1]
C0020615
known or suspected allergy to trial product or related products
Description

allergy to trial product

Type de données

boolean

Alias
UMLS CUI [1]
C0020517
use of any drug (except for ohas (oral hypoglycaemic agents), which in the investigator's opinion could interfere with the glucose level or body weight. stable doses, for 3 months or greater, of thyroid hormone replacement are allowed
Description

medication

Type de données

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0202042
UMLS CUI [1,3]
C0005910
Retour au début de la page

Similar models

Eligibility Diabetes NCT01508949

1 Formulaires
  1. StudyEvent: Eligibility
    1. Eligibility Diabetes NCT01508949
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
diabetes mellitus type 2
Item
type 2 diabetes mellitus
boolean
C0011849 (UMLS CUI [1,1])
C0441730 (UMLS CUI [1,2])
diet therapy; sulphonylurea or repaglinide
Item
diet treated and/or subjects in monotherapy with sulphonylurea or repaglinide
boolean
C0012159 (UMLS CUI [1])
C0038766 (UMLS CUI [2])
C0246689 (UMLS CUI [3])
hba1c
Item
hba1c for diet treated subjects 6.5-12%, both inclusive
boolean
C0019018 (UMLS CUI [1])
hba1c for sulphonylurea or repaglinide treated subjects
Item
hba1c for sulphonylurea or repaglinide treated subjects maximum 10%
boolean
C0038766 (UMLS CUI [1,1])
C0019018 (UMLS CUI [1,2])
C0246689 (UMLS CUI [2,1])
C0019018 (UMLS CUI [2,2])
bmi
Item
body mass index (bmi) at least 27 kg/m^2
boolean
C1305855 (UMLS CUI [1])
euthyroid
Item
euthyroid subjects
boolean
C0117002 (UMLS CUI [1])
fasting blood glucose
Item
fasting blood glucose 7-14 mmol/l
boolean
C0428568 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
impaired liver function
Item
impaired liver function
boolean
C0086565 (UMLS CUI [1])
impaired renal function
Item
impaired renal function
boolean
C0151746 (UMLS CUI [1])
cardiac problems
Item
cardiac problems
boolean
C0262402 (UMLS CUI [1])
hypertension
Item
uncontrolled treated/untreated hypertension
boolean
C0020538 (UMLS CUI [1])
hypoglycaemia
Item
recurrent severe hypoglycaemia as judged by the investigator
boolean
C0020615 (UMLS CUI [1])
allergy to trial product
Item
known or suspected allergy to trial product or related products
boolean
C0020517 (UMLS CUI [1])
medication
Item
use of any drug (except for ohas (oral hypoglycaemic agents), which in the investigator's opinion could interfere with the glucose level or body weight. stable doses, for 3 months or greater, of thyroid hormone replacement are allowed
boolean
C0013227 (UMLS CUI [1,1])
C0202042 (UMLS CUI [1,2])
C0005910 (UMLS CUI [1,3])
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial